RBC Capital Markets’s $85 target on PTCT

PTCT Ptc Therapeutics Inc

$63.7 → $85 (+33%) by Oct 2027

Sector Perform · reiterates · said Oct 7, 2026 · 12-month default horizon

Open: judged on the close on Oct 7, 2027

The article this target came from

RBC Capital reiterates PTC Therapeutics stock rating at Sector Perform

Investing.com · Oct 7, 2026

Investing.com - RBC Capital reiterated its Sector Perform rating on PTC Therapeutics (NASDAQ:PTCT) with an $85.00 price target.

RBC Capital Markets’s track record → Ptc Therapeutics Inc →

A fact about what RBC Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.